7 Westferry Circus ● Canary Wharf ● London E14 4HB ● United Kingdom An agency of the European Union Telephone +44 (0)20 7418 8400 Facsimile +44 (0)20 7523 7455 E-mail…

24 October 2013 EMA/697409/2013 Summary on compassionate use for Sofosbuvir Gilead International non-proprietary name: SOFOSBUVIR Procedure No. EMEA/H/K/003891/CU Note Assessment…

PAR Diclofenac Sodium 4% Spray Gel UK/H/0562-3/001/E01 1 Public Assessment Report Mutual Recognition Procedure Diclofenac Sodium 4% Spray Gel UK/H/0562-3/001/E01 Mika Pharma…

PAR-Oftaquix Unit Dose 5mg/ml Eye Drops UK/H/464/002/MR - 1 - Public Assessment Report Mutual Recognition Procedure Oftaquix Unit Dose 5 mg/ml Eye Drops UK/H/0464/002/MR…

1. 1 © The King’s Fund 2013How should wepay for health carein future?Results of deliberativeevents with the public Authors Amy Galea Anna Dixon Anastasia Knox Dan Wellings…

Slide 1 Identifying ProblemsâOutcomes for Judging System Performance Marc J Roberts Professor of Political Economy and Health Policy Harvard School of Public Health Nairobi,…

25 September 2014 EMA/702742/2014 Committee for Medicinal Products for Human Use (CHMP) Assessment report Harvoni International non-proprietary name: ledipasvir / sofosbuvir…

Liam Brennan Council member & revalidation lead Royal College of Anaesthetists Revalidation for anaesthetists Update - June 2012 Introduction Appraisal for revalidation…

Rapporteurâs Public Assessment Report for paediatric studies submitted in accordance with Article 45 of Regulation (EC) No1901/2006, as amended Dulcolax Prepacol Fenolax…